Back
EHRA Premium Access

No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry

Session: Atrial fibrillation ablation - Multicenter studies and registries
Topic: Catheter Ablation of Arrhythmias
Speaker: Doctor C. Jilek (Munich, DE)
Event: EHRA 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Clemens Jilek

Clinic for Internal Medicine South Munich, Munich (Germany)
2 presentations
0 follower

7 more presentations in this session

Uninterrupted Direct Oral Anticoagulant therapy is an efficacious and safer alternative to Vitamin K Antagonists in patients undergoing catheter ablation for atrial fibrillation. A meta-analysis

Speaker: Mr M. Ottoffy (Pecs, HU)

Access
Abstract
Like
Thumbnail

Ablation Strategies for different types of atrial fibrillation in Europe - Results of the EORP Atrial Fibrillation Ablation Long-Term Registry

Speaker: Doctor B. Schmidt (Frankfurt, DE)

Access
Abstract
Slides
Like
Thumbnail

Markedly reduced fluoroscopy time in catheter ablation: data from the Swedish national catheter ablation registry

Speaker: Doctor M. Ringborn (Karlskrona, SE)

Access
Abstract
Slides
Like
Thumbnail

Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicenter LAGO-AF Study

Speaker: Doctor F. Bisbal (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Influence of risk factors and co-morbidities on outcome, re-ablation and complications in the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry

Speaker: Doctor S. Trines (Leiden, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Atrial fibrillation ablation - Multicenter studies and registries

Speakers: Doctor C. Jilek, Mr M. Ottoffy, Doctor B. Schmidt, Doctor M. Ringborn, Doctor F. Bisbal...
Access
Like
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources